Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.

We have determined the extent of fragment X formation during thrombolytic therapy by integration over time of the plasma fibrinopeptide B beta 1-42 concentration. This peptide is quantitatively released when fragment X is formed by plasmin action on fibrinogen or fibrin I. In response to streptokina...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Owen, J, Friedman, K D, Grossman, B A, Wilkins, C, Berke, A D, Powers, E R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC424490/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2953761/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!